Pharmaceutical on the Net

With a focus on pipelines and Resources.

Amylin Pharmaceuticals: Pipeline
Amylin Pharmaceuticals, Inc. is a development pharmaceutical company focused on metabolic disorders, and specializing in preclinical characterization of lead molecules and demonstration of proof of principle in humans.
Axys Pharmaceuticals: Pipeline
Axys Pharmaceuticals has developed a broad pipeline of small molecule drugs to treat significant diseases, including asthma, blood clotting disorders, arthritis, osteoporosis, cancer, and inflammatory and infectious diseases.
Cortex Pharmaceuticals
Cortex believes that increasing AMPA receptor activity with AMPAKINEs will provide a new approach to treating a number of central nervous system disorders
Pipeline consisting of antiviral, cancer, automimmune & inflammation, neurological disorders.
PathoGenesis: Pipeline
Drug candidates and R&D approach, areas of R&D.
Abbott Laboratories: Pipeline
Our research focuses on developing compounds in five key areas: infectious diseases, neurological and urological diseases, immunologic diseases, metabolic diseases, and cancer.
Cor Therapeutics, Inc: Pipeline
Research and clinical development table of products in the pipeline.
OSI Pharmaceuticals: Product Pipeline
OSI Pharmaceuticals is a Pharmaceutical Research and Development Organization (PRDO) that utilizes a high tech, comprehensive drug discovery and development capability to rapidly and cost effectively discover and develop novel, small molecule dr.
Product portfolio in development, and marketed products.
Amgen Marketed Products and Pipeline Candidates
Medco Research: Product Portfolio
Medco Research is dedicated to being a leader in the global commercialization of cardiovascular medicines and adenosine-based products leading to superior growth in shareholder value.
Genetics Institute, Inc.
Genetics Institute, Inc., is developing a portfolio of proprietary products including blood cell growth factors, bone-inducing proteins, and agents to treat cancer, infectious disease and hemophilia
ZymeTx, Inc.
ViraZyme Technology based product pipeline.
New Drugs provides a timely profile of all pharmaceutical substances designed for the United States market.
Tularik: Pipeline
Our pipeline includes two cancer drug candidates in clinical testing, one cancer drug candidate for which an Investigational New Drug application has been approved, one preclinical cytomegalovirus drug candidate and 14 drug leads in our other pr.
Nb of rev= 15